Standard Biotools
Quarterly Financials
| Values in thousands | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
Revenue | $21,146 | $23,795 | $19,552 | $21,762 |
Gross Profit | 11,308 | 10,240 | 9,484 | 10,628 |
EBITDA | -8,008 | -20,637 | -21,870 | -21,699 |
EBIT | -9,416 | -21,924 | -23,467 | -23,699 |
Net Income | -45,221 | 19,283 | -34,687 | -33,459 |
Net Change In Cash | 21,146 | 23,795 | 19,552 | 21,762 |
Free Cash Flow | -47,167 | -1,673 | -23,088 | -22,555 |
Cash | 265,772 | 118,213 | 129,418 | 158,617 |
Basic Shares | 388,202 | 385,048 | 382,630 | 380,498 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $85,331 | $174,432 | $106,340 | $97,948 |
Gross Profit | 42,543 | 84,262 | 50,450 | 37,051 |
EBITDA | -86,323 | -118,135 | -54,457 | -173,570 |
EBIT | -93,305 | -134,996 | -69,637 | -188,597 |
Net Income | -74,896 | -138,885 | -74,656 | -190,098 |
Net Change In Cash | 85,331 | 174,432 | 106,340 | 97,948 |
Cost of Revenue | 53,261 | |||
Free Cash Flow | -82,653 | -151,809 | -46,118 | -93,195 |
Cash | 118,213 | 166,728 | 51,704 | 81,309 |
Basic Shares | 381,623 | 352,670 | 79,160 | 78,305 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-03-31 | -$0.02 |
2025-12-31 | $0.06 |
2025-09-30 | -$0.04 |
2025-06-30 | -$0.05 |